SHC Sotera Health Company
USHealthcareAs of 2026-07-10 16:00
Why SHC matters now
Sotera Health Company (SHC) is a US stock in Healthcare. The latest InvestLog snapshot shows $18.42 with +0.16% on the session and $5.25B in market capitalization; recent performance reads 1-month +3.87% and YTD -10.32%.
The latest financial table shown here is Q1 2026, with revenue of $280.0M, net income of $26.6M, and EPS of $0.09. Investors can compare that operating picture with valuation signals such as P/E 53.41 and FCF yield 2.1%.
The latest indexable market news headline is "Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $22.00; recent insider activity includes SHADER ALTON filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
53.41
PEG
0.71
P/B
7.24
P/S
3.79
EV/EBITDA
13.23
DCF Value
$-1.59
FCF Yield
2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
35.5%
Net Margin
9.9%
ROE
20.6%
ROA
3.6%
ROIC
8.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $280.0M | $26.6M | $0.09 |
| Q4 2025 | $303.4M | $34.8M | $0.12 |
| FY 2025 | $1.16B | $77.9M | $0.27 |
| Q3 2025 | $311.3M | $48.4M | $0.17 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$21.50
Target (Median)
$22.00
Target Range
$18.00 - $24.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
1.80
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.